Abstract: The embodiments of the disclosure provide a method for pose correction and a host. The method includes: obtaining a first image; in response to determining that a first reference object of at least one reference object exists in the first image, determining a first relative position between the host and the first reference object; obtaining a first reference pose based on the first relative position; and correcting a pose of the host based on the first reference pose.

Abstract: An extraction method of Hibiscus sabdariffa L. ‘TAITUNG NO. 6’, a Hibiscus sabdariffa L. ‘TAITUNG NO. 6’ extract using the same, and uses thereof are provided. The extraction method includes: providing the Hibiscus sabdariffa L. ‘TAITUNG NO. 6’ that is dried as a raw material for extraction; pulverizing the raw material; mixing the raw material that is pulverized with an extraction solvent for primary extraction, so as to obtain a Hibiscus sabdariffa L. ‘TAITUNG NO. 6’ primary extract; performing ultrasonic extraction on the Hibiscus sabdariffa L. ‘TAITUNG NO. 6’ primary extract, so as to obtain a Hibiscus sabdariffa L. ‘TAITUNG NO. 6’ extract; and filtering the Hibiscus sabdariffa L. ‘TAITUNG NO. 6’ extract.

Abstract: The presently disclosed subject matter aims to a system and method directed to monitor the effect of a herpesvirus-based vaccine in an animal population. The system and method include a processing circuitry configured to: obtain one or more tissue samples of one or more respective animals of the animal population; sequence each of the tissue samples; calculate a score associated with the animal population based on the sequence of the tissue samples; compare the score to a benchmark determined from a dataset containing data associated with the effect of the herpesvirus-based vaccine in a plurality of animal populations; and, execute an action in response to the comparison to the benchmark.

Abstract: The present invention provides a bi-functional fusion protein, (AT)a-Fc-(VT)b, simultaneously targeting vascular endothelial growth factor (VEGF) and angiopoietins (ANGs), wherein AT is an ANG binding motif; and VT is a VEGF binding motif, Fragment crystallizable region (Fc) is an N-terminal of Immunoglobulin G (IgG); each of a and b is an integer from 1 to 10. The bi-functional fusion proteins contain two or more domains of human proteins and are of all human sequences, and thus are expected to be non-immunogenic, and potentially can be used therapeutically in human targeting angiogenesis-associated diseases.

Abstract: A semiconductor die includes a semiconductor substrate, a dielectric layer over the semiconductor substrate, a metal structure in the dielectric layer, a first metal pad over the metal structure, a first oxide-based passivation layer over the first metal pad, a second oxide-based passivation layer over the first oxide-based passivation layer, and a bump electrically connected to the first metal pad. The second oxide-based passivation layer has a hardness less than a hardness of the first oxide-based passivation layer.

Abstract: A head-mounted display device is provided. The head-mounted display device includes a camera, a controller, and a display. The camera is configured to obtain an environment image of an environment around a user. The controller is configured to extract a plurality of feature points from the environment image and output an analysis result of a user pose of the user based on the plurality of feature points. The display is configured to display the environment image based on the analysis result.

Abstract: The present invention relates to a preferably computer-implemented method of raising a group of monogastric animals Issues such as exposure of the animals to an initiator of a disease are recognized at an early stage by ex vivo analysis of blood samples. Said analysis is done where the animals are raised using point-of-care devices. Accuracy of separation between affected and non-affected animals is increased by measuring a set of pre-determined blood parameters. The landless monogastric animal production system of the invention facilitates implementation of the method of the invention.

Abstract: The embodiments of the disclosure provide a method for pose correction and a host. The method includes: obtaining a first image; in response to determining that a first reference object of at least one reference object exists in the first image, determining a first relative position between the host and the first reference object; obtaining a first reference pose based on the first relative position; and correcting a pose of the host based on the first reference pose.

Abstract: The embodiments of the disclosure provide a method for determining a floor plane and a host. The method includes: determining a first plane as a reference floor plane based on motion data; in response to determining that the host has moved for a predetermined distance after determining the first plane as the reference floor plane, determining a plurality of first feature points on the reference floor plane; determining a second plane based on the first feature points on the reference floor plane; and in response to determining that the second plane meets a predetermined condition, determining the second plane as the reference floor plane.

Abstract: A wearable device is provided. The wearable device includes a processor. The processor is configured to: receive a user instruction, wherein the user instruction comprises a first virtual point and a second virtual point in a virtual world; obtain a first real point and a second real point in a real world respectively based on the first virtual point and the second virtual point according to an environment map around the wearable device; and determine a real distance between the first real point and the second real point.

Abstract: The present invention provides a bi-functional fusion protein, (AT)a-Fc-(VT)b, simultaneously targeting vascular endothelial growth factor (VEGF) and angiopoietins (ANGs), wherein AT is an ANG binding motif; and VT is a VEGF binding motif, Fragment crystallizable region (Fc) is an N-terminal of Immunoglobulin G (IgG); each of a and b is an integer from 1 to 10. The bi-functional fusion proteins contain two or more domains of human proteins and are of all human sequences, and thus are expected to be non-immunogenic, and potentially can be used therapeutically in human targeting angiogenesis-associated diseases.

Abstract: A semiconductor die includes a semiconductor substrate, a dielectric layer over the semiconductor substrate, a metal structure in the dielectric layer, a first metal pad over the metal structure, a first oxide-based passivation layer over the first metal pad, a second oxide-based passivation layer over the first oxide-based passivation layer, and a bump electrically connected to the first metal pad. The second oxide-based passivation layer has a hardness less than a hardness of the first oxide-based passivation layer.

Abstract: A method is provided. A bottom passivation layer is formed on a dielectric layer over a semiconductor substrate. Then, a first opening is formed in the bottom passivation layer to expose a portion of the dielectric layer. Next, a metal pad is formed in the first opening. Afterwards, a first oxide-based passivation layer is formed over the metal pad. Then, a second oxide-based passivation layer is formed over the first oxide-based passivation layer. The second oxide-based passivation layer has a hardness less than a hardness of the first oxide-based passivation layer.

Abstract: The present invention provides antibodies that bind to CD47 with high affinity and specificity, and their use in treatment of a cancer.

Abstract: The present invention provides a bi-functional fusion protein, (AT)a-Fc-(VT)b, simultaneously targeting vascular endothelial growth factor (VEGF) and angiopoietins (ANGs), wherein AT is an ANG binding motif; and VT is a VEGF binding motif, Fragment crystallizable region (Fc) is an N-terminal of Immunoglobulin G (IgG); each of a and b is an integer from 1 to 10. The bi-functional fusion proteins contain two or more domains of human proteins and are of all human sequences, and thus are expected to be non-immunogenic, and potentially can be used therapeutically in human targeting angiogenesis-associated diseases.

Abstract: A method is provided. A bottom passivation layer is formed on a dielectric layer over a semiconductor substrate. Then, a first opening is formed in the bottom passivation layer to expose a portion of the dielectric layer. Next, a metal pad is formed in the first opening. Afterwards, a first oxide-based passivation layer is formed over the metal pad. Then, a second oxide-based passivation layer is formed over the first oxide-based passivation layer. The second oxide-based passivation layer has a hardness less than a hardness of the first oxide-based passivation layer.

Abstract: A method is provided. A bottom passivation layer is formed on a dielectric layer over a semiconductor substrate. Then, a first opening is formed in the bottom passivation layer to expose a portion of the dielectric layer. Next, a metal pad is formed in the first opening. Afterwards, a first oxide-based passivation layer is formed over the metal pad. Then, a second oxide-based passivation layer is formed over the first oxide-based passivation layer. The second oxide-based passivation layer has a hardness less than a hardness of the first oxide-based passivation layer.

Abstract: The present invention provides a bi-functional fusion protein simultaneously targeting the complement and the vascular endothelial growth factor (VEGF). The bi-functional fusion proteins contain two or more domains of human proteins and are of all human sequences, and thus are expected to be non-immunogenic, and potentially can be used therapeutically in human targeting complement and VEGF related diseases.

Abstract: The present invention provides a bi-functional fusion protein, (AT)a-Fc-(VT)b, simultaneously targeting vascular endothelial growth factor (VEGF) and angiopoietins (ANGs), wherein AT is an ANG binding motif; and VT is a VEGF binding motif, Fc is an N-terminal of IgG; each of a and b is an integer from 1 to 10. The bi-functional fusion proteins contain two or more domains of human proteins and are of all human sequences, and thus are expected to be non-immunogenic, and potentially can be used therapeutically in human targeting angiogenesis-associated diseases.

Abstract: A method includes receiving an input from a user, the input including a selection of an object, where the object is contained in a video, identifying, in response to the input, the object in the video, determining an attribute of the object associated with a profile of the user, where the profile contains a preference of the user regarding at least one object to be viewed, and determining, in response to the attribute of the object associated with the profile, a target segment in the video, where the target segment includes the object.